A novel multi-target small molecule (NLOC-15A) for the treatment of NSCLC
Source: NCBI BioProject (ID PRJNA809872)

0 0

Project name: Homo sapiens
Description: We reported the therapeutic potential of NLOC-015A, a novel small molecule for the treatment of NSCLC. We treated H1975 with NLOC-015A for 48 hr. The total RNA was extracted from the treated as well as the control cells using TRIzol reagent, after which we performed RNA-sequencing to compare DEGs between control H1975 cells and NLOC-015-treated NSCLC cells.
Data type: transcriptome
Sample scope: Multiisolate
Organization: Taipei Medical University
Last updated: 2022-02-24
Statistics: 2 samples; 2 experiments; 2 runs